OR09 Pituitary Tumors-Therapeutics

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Neuroendocrinology and Pituitary-Clinical/Translational
Thursday, March 5, 2015: 11:30 AM-1:00 PM
Room 31 (San Diego Convention Center)
**This session is NOT eligible for CME credit**

Chairs:
Laurence Katznelson, MD, Stanford Univ, Stanford, CA and Eliza B. Geer, MD, Icahn School of Medicine at Mount Sinai, New York City, NY

Disclosures:
LK: Advisory Group Member, Novartis Pharmaceuticals, Advisory Group Member, Genentech, Inc., Investigator, Novartis Pharmaceuticals, Advisory Group Member, Pfizer, Inc.. Nothing to Disclose: EBG Disclosure Not Provided: LSK, CJS, SMW
11:30 AM
Peter James Trainer, Endocrinology, The Christie NHS Foundation Trust, Manchester, United Kingdom, John David Charles Newell-Price, MD, PhD, FRCP, Schl of Med and Biomed Sci, Univ of Sheffield, Sheffield, United Kingdom, John Ayuk, MD, MRCP, Queen Elizabeth Hospital, University Hospital Birmingham, Birmingham, United Kingdom, Simon J B Aylwin, MD, FRCP, PHD, Department of Endocrinology, King's College Hospital, London, United Kingdom, Aled Rees, MD, PhD, Center for Endocrine & Diabetes Sciences, Cardiff University, Cardiff, United Kingdom, William Drake, Endocrinology, St Bartholomew's Hospital, London, United Kingdom, Philippe Chanson, MD, Hôpital de Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Univ Paris-Sud, UMR-S693, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre, France, Thierry Brue, MD, PhD, Service d'Endocrinologie, Centre de Référence des Maladies rares d’origine hypophysaire, Hopital de la Conception, Marseille, France, Susan M. Webb, MD, PhD, Univ Autonoma de Barcelona, Hosp de Sant Pau, Barcelona, Spain, Carmen Fajardo, MD, Department of Endocrinology, Hospital Universitario La Ribera, Alzira. Valencia, Spain, Javier Aller, Endocrinology, Hospital Universitario Puerta de Hierro, Madrid, Spain, Ann I McCormack, MD PhD, Department of Endocrinology, St. Vincent Hospital, Naremburn - NSW, Australia, David J Torpy, MBBS, FRACP, PhD, Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia, George Tachas, Antisense Therapeutics, Melbourne, Australia, Lynne Atley, Antisense Therapeutics Limited, Melbourne, Australia and M Bidlingmaier, Medizinische Klinik IV – Endocrinology, Ludwig-Maximilians University, Munich, Germany
11:45 AM
Lillian Ting, PhD1, Anadya Prakash Tripathi, MSc2, Christelle Darstein, MS3, Tracy White, MS1 and Nicholas Sauter, MD1, (1)Novartis Pharmaceuticals Corporation, East Hanover, NJ
(2)Novartis Healthcare Pvt Ltd, Hyderabad, India
(3)Novartis Pharma AG, Basel, Switzerland
12:00 PM
Shlomo Melmed, MB, ChB, Academic Affairs Administration, Cedars-Sinai Medical Center, Los Angeles, CA, Nienke R. Biermasz, MD, PhD, Endocrinology and Metabolism, Center for Endocrine Tumors Leiden, Leiden University Medical Center, Netherlands, Peter J Trainer, The Christie NHS Foundation Trust, Department of Endocrinology, Manchester, United Kingdom, Gary Patou, Chiasma Inc,, Newton and Asi Haviv, Chiasma, Jerusalem, Israel
12:15 PM
Aart Jan van der Lely, MD, PhD, Department of Medicine, Erasmus University Medical Center, Rotterdam, Netherlands, Peter J. Jonsson, MSc, Endocrine Care, Pfizer Health AB, Sollentuna, Sweden, Patrick Wilton, MD, PhD, Stockholm, Sweden, Jose Francisco Cara, MD, BSc, Endocrine Care, Pfizer Inc, New York, NY and Ezio G G M Ghigo, MD, PhD, Division of Endocrinology, Diabetology and Metabolism. Dept of Medical Sciences, University of Turin, Turin, Italy
12:30 PM
Greisa Vila, MD1, Ann-Charlotte Akerblad, PhD2, Anders F. Mattsson, PhD2, Michaela Riedl, MD3, Susan M. Webb, MD, PhD4, Vaclav Hana, MD, PhD5, Eigil H Nielsen, MD, PhD6, Beverly M.K. Biller, MD, FACP7 and Anton Luger, MD, PhD8, (1)Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
(2)Endocrine Care, Pfizer Health AB, Sollentuna, Sweden
(3)Division of Endocrinology and Metabolism, Department of Internal Medicin III, Medical University of Vienna, Vienna, Austria
(4)Endocrinology/Medicine Departments, Hospital Sant Pau, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
(5)Third Deparment of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
(6)Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
(7)Neuroendocrine Clinical Center, Massachusetts General Hospital, Boston, MA
(8)Division of Endocrinology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
12:45 PM
Katarzyna Kryzanowska-Mittermayer, MD1, Anton Luger, MD, PhD2, Dominique Maiter, MD, PhD3, Ulla Feldt-Rasmussen, Professor, MD, DMSc4, Anders F. Mattsson, PhD5, Ann-Charlotte Akerblad, PhD5, Cecilia Camacho-Hubner, MD, PhD6 and Roger Abs, MD, PhD7, (1)Medical Department, Rudolfstiftung Hospital, Vienna, Austria
(2)Division of Endocrinology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
(3)Department of Endocrinology and Nutrition, UCL St Luc Hospital, Brussels, Belgium
(4)Dept of Medical Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
(5)Endocrine Care, Pfizer Health AB, Sollentuna, Sweden
(6)Endocrine Care, Pfizer Inc, New York, NY
(7)Edegem, Belgium